Innovating Works

GENOS

Desconocido
EXPAND-EV: EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision heal... Extracellular vesicles (EVs) have been identified as important signaling mediators in a myriad of physiological and pathological processes....
2024-08-19 - 2028-12-31 | Financiado
SynHealth: Synergy for Healthy Longevity GENOS DOO ZA VJESTACENJE I ANALIZU tramitó un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-04 Almost all current healthcare systems are based on treating individuals who are already ill, relying on periodic interventions when health i...
2024-03-01 - 2027-02-28 | Financiado
OMRP: O-Glc-NAc modifications of RNA-binding proteins GENOS DOO ZA VJESTACENJE I ANALIZU participó en un HORIZON EUROPE: HORIZON-WIDERA-2022-TALENTS-04 O-GlcNAcylation is a post-translational dynamic modification of proteins that is becoming more widely recognized as a modification that can...
2023-05-11 - 2025-08-31 | Financiado
geneTIGA: Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome edit... GENOS DOO ZA VJESTACENJE I ANALIZU participó en un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 "There is an increasing prevalence of chronic diseases caused by undesired immune reactions (>10%) with high burden for the both patients (c...
2022-05-23 - 2026-06-30 | Financiado
3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... GENOS DOO ZA VJESTACENJE I ANALIZU participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado
Back-UP: Personalised Prognostic Models to Improve Well being and Return to Work After Neck and Low Back Pain GENOS DOO ZA VJESTACENJE I ANALIZU participó en un H2020: H2020-SC1-2016-2017 Neck and low back pain (NLBP) are leading causes for years lived with disability in Europe and worldwide. About 70% of all adults experience...
2017-10-16 - 2021-04-30 | Financiado
IMforFUTURE: Innovative training in methods for future data GENOS DOO ZA VJESTACENJE I ANALIZU participó en un H2020: H2020-MSCA-ITN-2016 IMforFUTURE is an innovative multidisciplinary and intersectoral research training programme which addresses current shortcomings in omics r...
2017-03-13 - 2021-07-31 | Financiado
SYSCID: A Systems medicine approach to chronic inflammatory disease GENOS DOO ZA VJESTACENJE I ANALIZU participó en un H2020: H2020-SC1-2016-2017 "The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indicatio...
2016-12-01 - 2022-09-30 | Financiado
GlySign: Exploitation of Glycosylation Signatures for Precision Medicine GENOS DOO ZA VJESTACENJE I ANALIZU participó en un H2020: H2020-MSCA-ITN-2016 GlySign is a research training network for the translation of glycomic clinical biomarkers for Precision Medicine (PM). Complex, distinctive...
2016-07-06 - 2020-09-30 | Financiado
GlyCoCan: Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therap... GENOS DOO ZA VJESTACENJE I ANALIZU participó en un H2020: H2020-MSCA-ITN-2015 Colorectal cancer (CRC) is a major worldwide cancer burden with about 1.4 million cases in 2012 and an annual mortality of approximately 700...
2015-08-07 - 2019-08-31 | Financiado
HTP-GLYCOMET: Methods for high throughput glycoproteomic analysis GENOS DOO ZA VJESTACENJE I ANALIZU participó en un FP7: The main aim of the HTP-GlycoMet proposal is to develop technologies, which will enable high-throughput analysis of glycosylation of individ...
Financiado
MIMOMICS: Methods for Integrated analysis of Multiple Omics datasets GENOS DOO ZA VJESTACENJE I ANALIZU participó en un FP7: MIMOmics develops statistical methods for the integrated analysis of metabolomics, proteomics, glycomics and genomic datasets in large studi...
Financiado
GLYCOBIOM: Tools for the Detection of Novel Glyco biomarkers GENOS DOO ZA VJESTACENJE I ANALIZU participó en un FP7: Glycosylation patterns on glycoproteins and glycolipids are involved in the regulation of inter- and intracellular recognition events and al...
Financiado
HIGHGLYCAN: Methods for high throughput HTP analysis of protein glycosylation GENOS DOO ZA VJESTACENJE I ANALIZU participó en un FP7: Glycosylation is a post-translational modification that enriches protein complexity and function. Dysregulation of glycosylation is associat...
Financiado
PAIN-OMICS: Multi dimensional omics approach to stratification of patients with low back pain GENOS DOO ZA VJESTACENJE I ANALIZU participó en un FP7: "Pain-OMICS is a multidisciplinary consortium of leading clinical, academic and SME researchers in pain and different omics technologies. Ge...
Financiado
IBD-BIOM: Diagnostic and prognostic biomarkers for inflammatory bowel diseaseIBD BIOM GENOS DOO ZA VJESTACENJE I ANALIZU participó en un FP7: Inflammatory bowel diseases affect 0.8% of the Europeans, and are associated with high morbidity, definite mortality and an increasing econo...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.